AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis

NCT06665165 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

ALS

Interventions

DRUG: AMX0114
OTHER: Placebo

Sponsor

Amylyx Pharmaceuticals Inc.